RVL Pharmaceuticals plc Quarterly Interest Expense in USD from Q3 2017 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
RVL Pharmaceuticals plc quarterly/annual Interest Expense history and growth rate from Q3 2017 to Q2 2023.
  • RVL Pharmaceuticals plc Interest Expense for the quarter ending June 30, 2023 was $13K, a 98.7% decline year-over-year.
  • RVL Pharmaceuticals plc Interest Expense for the twelve months ending June 30, 2023 was $1.19M, a 70.2% decline year-over-year.
  • RVL Pharmaceuticals plc annual Interest Expense for 2022 was $3.11M, a 2.44% increase from 2021.
  • RVL Pharmaceuticals plc annual Interest Expense for 2021 was $3.04M, a 25.9% decline from 2020.
  • RVL Pharmaceuticals plc annual Interest Expense for 2020 was $4.1M, a 31.9% decline from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $1.19M $13K -$965K -98.7% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.15M $26K -$959K -97.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.11M $15K -$1.27M -98.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-20
Q3 2022 $4.38M $1.13M +$397K +54% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.98M $978K +$484K +98% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $3.5M $985K +$464K +89.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $3.04M $1.29M +$3.57M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-20
Q3 2021 -$529K $735K -$336K -31.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$193K $494K -$745K -60.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $552K $521K -$3.54M -87.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $4.1M -$2.28M +$5.26M +69.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$1.17M $1.07M -$3.43M -76.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $2.26M $1.24M -$3.31M -72.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $5.58M $4.06M -$437K -9.71% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $6.01M -$7.54M -$12.9M -240% Oct 1, 2019 Dec 31, 2019 8-K 2021-09-08
Q3 2019 $19M $4.5M -$807K -15.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $19.8M $4.55M -$689K -13.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $20.4M $4.5M -$342K -7.06% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $20.8M $5.39M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-19
Q3 2018 $5.31M -$1.99M -27.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $5.24M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $4.84M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q3 2017 $7.3M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.